BOSTON BIOTECHNOLOGY CORPORATION

Basic Information

BOSTON BIOTECHNOLOGY CORPORATION
64 GROVE STREET
WATERTOWN, MA, 02472

Company Profile

n/a

Additional Details

Field Value
DUNS: n/a
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. GHRELIN VACCINES FOR CONTROLLING OBESITY

    Amount: $749,874.00

    DESCRIPTION (provided by applicant): Obesity has reached epidemic proportions in the United States and adversely affects the health of both adults and children. While dieting and exercise have had lit ...

    SBIR Phase II 2006 Department of Health and Human Services
  2. GHRELIN VACCINES FOR CONTROLLING OBESITY

    Amount: $74,098.00

    DESCRIPTION (provided by applicant): Obesity has reached epidemic proportions in the United States and adversely affects the health of both adults and children. While dieting and exercise have had lit ...

    SBIR Phase I 2005 Department of Health and Human Services
  3. EPITOPE-SPECIFIC ANTIBODIES FOR ALZHEIMER'S DISEASE

    Amount: $749,874.00

    DESCRIPTION (provided by applicant): Recent attempts at treating Alzheimer's patients with a beta-amyloid vaccine have resulted in an adverse brain inflammation response for a significant number in th ...

    SBIR Phase II 2004 Department of Health and Human Services
  4. EPITOPE-SPECIFIC ANTIBODIES FOR ALZHEIMER'S DISEASE

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): Recent attempts at treating Alzheimer's patients with a beta-amyloid vaccine have resulted in an adverse brain inflammation response for a significant number in th ...

    SBIR Phase I 2003 Department of Health and Human Services
  5. HTS for Protein Splicing Inhibitors as TB Drugs

    Amount: $297,643.00

    DESCRIPTION (provided by applicant): One-third of the world' s population (2 billion people) are infected with Mycobacterium tuberculosis and 5-10% of these suffer active tuberculosis, leading to nea ...

    SBIR Phase I 2003 Department of Health and Human Services
  6. N/A

    Amount: $0.00

    N/A

    SBIR Phase I 2000 Department of Health and Human Services
  7. N/A

    Amount: $378,083.00

    N/A

    SBIR Phase II 2000 Department of Health and Human Services
  8. IMMUNOTHERAPY OF ALZHEIMERS DISEASE

    Amount: $99,489.00

    N/A

    SBIR Phase I 1998 Department of Health and Human Services
  9. CATALYTIC ANTIBODIES FOR THE TREATMENT OF AIDS

    Amount: $99,911.00

    N/A

    SBIR Phase I 1996 Department of Health and Human Services
  10. SUPERACTIVE B-GALACTOSIDASE FOR ENZYME IMMUNOASSAY

    Amount: $50,000.00

    IN DIAGNOSTIC ENZYME IMMUNOASSAYS (EIA'S), ENZYMES ARE CONJUGATED WITH EITHER ANTIGEN OR ANTIBODY TO AMPLIFY THE PRESENCE OF ANTIGEN-ANTIBODY COMPLEXES. CURRENTLY, BETA-GALACTOSIDASE, HORSERADISH PERO ...

    SBIR Phase I 1989 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government